VTRS250117P8000
- 0.19
- 0.000.00%
Viatris Newsroom
The bad news from the U.S. stock market may have been fully digested! It's time for investors to focus on this type of Stocks.
The bad news may have already been fully absorbed, and factors such as profits, valuations, and long-term underperformance are expected to help value stocks catch up.
The USA FDA has restricted the import of some products produced by Viatris' pharmaceutical plant in India.
On December 23, Glonghui reported that Viatris announced on Monday that the USA Food and Drug Administration (FDA) has imposed import restrictions on 11 products produced at its manufacturing facility in India, due to violations of federal requirements. The FDA issued a warning letter to the pharmaceutical company after inspecting the facility, stating that these products will no longer be accepted in the USA until the warning letter is lifted. Viatris indicated that the FDA made conditional exceptions for four products based on shortage issues. The company has immediately implemented a remediation plan on-site and stated that necessary corrective and preventive measures are proceeding smoothly. The company has also hired
Viatris Issues Statement Regarding Receipt Of Warning Letter And Import Alert For Indore, India Facility; The Import Alert Affects 11 Actively Distributed Products That Will No Longer Be Accepted Into The U.S. Until The Warning Letter Is Lifted
Express News | Viatris Inc: There Could Be Potential for Additional Exceptions by FDA Based on Further Discussions Related to Import Alert
Express News | Viatris: Engaged Independent Third-Party Subject Matter Experts to Support Remediation Plan
Express News | Viatris: Necessary Corrective and Preventive Actions Well Underway, Including but Not Limited to Related Personnel Actions
Express News | Viatris: Do Not Anticipate Actions to Impact Current 2024 Financial Guidance Ranges
Express News | Viatris Inc: Import Alert Affects 11 Actively Distributed Products That Will No Longer Be Accepted Into U.S. Until Warning Letter Is Lifted
Express News | Viatris Statement Regarding Receipt of Warning Letter and Import Alert for Indore, India Facility
How to find the "alpha" market in U.S. stocks next year? Goldman Sachs provides an investment guide.
Zhihui Finance has learned that Goldman Sachs analysts said in a report that over the next six months, the materials, Software, and services industries in the USA are most likely to outperform the Large Cap. Goldman Sachs strategist David Kostin stated in a report on December 20 that they introduced a model for USA Stocks to select industries expected to exceed the benchmark Index by 5 percentage points or more, "to identify 'high conviction' views with significant Alpha potential." He noted, "Our model incorporates macro, fundamental, and valuation data as independent variables. We run probability models separately for each Industry, only including
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Daily short sale tracking: Palantir's short volume increased by 51 million, with a short sale ratio of 23%
Palantir(PLTR.US) ranked top of the list had the largest change in short volume (51.06 million shares), and the short volume ratio of UL Solutions(ULS.US) reached 57.15%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
UBS Says 'Underweight the Names With High China Exposure'
Viatris Announces Publication Of Phase 2b CARE Study Results For Cenerimod, Demonstrating Efficacy In Moderate-To-Severe Lupus
Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology
Jefferies Maintains Viatris(VTRS.US) With Buy Rating, Maintains Target Price $15
Piper Sandler Maintains Viatris(VTRS.US) With Hold Rating, Raises Target Price to $14
Daily short sale tracking: Palantir's short volume increased by 5 million, with a short sale ratio of 11%
Palantir(PLTR.US) ranked top of the list had the largest change in short volume (5.88 million shares), and the short volume ratio of Canadian Natural Resources(CNQ.US) reached 45.11%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
Mapi Pharma Is Seeking New Depot Product Partnerships